Nektar Therapeutics reported $19.06M in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Agios Pharmaceuticals AGIO:US USD 5.18M 1.12M
ALKERMES ALKS:US USD 166.3M 10.69M
Amgen AMGN:US USD 4.76B 203M
Baxter International BAX:US USD 2.68B 12M
Biogen BIIB:US USD 1.38B 80.8M
Bristol Myers Squibb BMY:US USD 2.07B 68M
Cara Therapeutics CARA:US USD 1.84M 1.62M
Eisai 4523:JP JPY 114.41B 10.9B
Eli Lilly And LLY:US USD 3.83B 68.3M
Esperion Therapeutics ESPR:US USD 29.54M 313K
Exelixis EXEL:US USD 26.71M 6.31M
Gilead Sciences GILD:US USD 2.6B 15M
GlaxoSmithKline GSK:LN GBP 4.66B 5M
Halozyme Therapeutics HALO:US USD 103.28M 5.66M
IONIS PHARMACEUT IONS:US USD 20.64M 834K
Karyopharm Therapeutics KPTI:US USD 4.25M 779K
Macrogenics MGNX:US USD 1.09M 1.86M
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Neurocrine Biosciences NBIX:US USD 37M 7.7M
Novartis NOVN:VX USD 6.78B 101M
Sarepta Therapeutics SRPT:US USD 221.19M 13.1M
Seattle Genetics SGEN:US USD 364.97M 45.62M
Takeda 4502:JP JPY 953.45B 25.94B
Teva Pharmaceutical TEVA:IT USD 3.86B 190M
YTE INCY:US USD 45.87M 8.63M